Abstract
The object of this paper is to present a broad spectrum of the morphologic changes that have been associated with cytostatic agents. This discussion is based on a retrospective study of biopsy and autopsy material from 155 human cases as seen by the practicing pathologist. These adverse changes are a measure of the failure of these drugs to preferentially inhibit or destroy neoplastic tissues while leaving the normal host tissues unaffected.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
BONADONNA, G., MONFARDINI, S.: Lancet 1969 1, 837.
BURNET, P.: Lancet 1967 1, 1171.
Editorial: Ann. int. Med. 75, 310 (1971).
Leading Article: Brit. med. J. 1967 2, 587.
MCKENZIE, J., CRAIG, J.: Arch. Dis. Childh. 30, 391 (1955).
MARMONT, A. M., DAMASIO, E., ROSSI, F.: Lancet 1969 1, 837.
SCHOCHET, S. S., JR., LAMPERT, P. W., EARLE, K. M.: J. Neuropath, exp. Neurol. 27, 645 (1968).
SCHOCHET, S. S. JR., LAMPERT, P. W., EARLE, K. M.: Exp. Neurol. 23, 113 (1969).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Irey, N.S. (1975). Adverse Reactions to Cytostatic Agents. In: Grundmann, E., Gross, R.W.J. (eds) The Ambivalence of Cytostatic Therapy. Recent Results in Cancer Research, vol 52. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80940-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-80940-8_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80942-2
Online ISBN: 978-3-642-80940-8
eBook Packages: Springer Book Archive